National Center for Complementary & Alternative Medicine; Notice of Closed Meeting, 42860 [06-6548]

Download as PDF 42860 Federal Register / Vol. 71, No. 145 / Friday, July 28, 2006 / Notices Expression Laboratory is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize in vitro assembly of protein microarrays. Please contact Betty Tong at 301–594–4263 or tongb@mail.nih.gov for more information. Dated: July 24, 2006. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E6–12132 Filed 7–27–06; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Alternative Medicine; Notice of Closed Meeting rwilkins on PROD1PC63 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Council for Complementary and Alternative Medicine (NACCAM) meeting. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Complementary and Alternative Medicine. Date: September 8, 2006. Closed: 9 am. to 2 p.m. Agenda: To review and evaluate grant applications and/or proposals. Open: 2 p.m. to 4 p.m. Agenda: Presentations of new research initiatives, and other council related business. VerDate Aug<31>2005 17:47 Jul 27, 2006 Jkt 208001 Place: National Institutes of Health, Neuroscience Building, 6001 Executive Boulevard, Rooms C & D, Rockville, MD 20852. Contact Person: Martin H. Goldrosen, PhD, Executive Secretary, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594–2014. The public comments session is scheduled from 3:30–4p.m. but could change depending on the actual time spent on each agenda item. Each speaker will be permitted 5 minutes for their presentation. Interested individuals and representatives of organizations are requested to notify Dr. Martin H. Goldrosen, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301– 594–2014, Fax: 301–480–9970. Letters of intent to present comments, along with a brief description of the organization represented, should be received no later than 5 p.m. on August 29, 2006. Only one representative of an organization may present oral comments. Any person attending the meeting who does not request an opportunity to speak in advance of the meeting may be considered for oral presentation, if time permits, and at the discretion of the Chairperson. In addition, written comments may be submitted to Dr. Martin H. Goldrosen at the address listed above up to ten calendar days (September 18, 2006) following the meeting. Copies of the meeting agenda and the roster of members will be furnished upon request by contacting Dr. Martin H. Goldrosen, Executive Secretary, NACCAM, National Center for Complementary and Alternative Medicine, National Institutes of Health, 6707 Democracy Boulevard, Suite 401, Bethesda, Maryland 20892, 301–594– 2014, Fax: 301–480–9970, or via e-mail at naccames@mail.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance into the building by nongovernment employees. Persons without a government I.D. will need to show a photo I.D. and sign-in at the security desk upon entering the building. Dated: July 24, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–6548 Filed 7–26–06; 8:45 am] BILLING CODE 4167–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Review of Behavioral Cardiology Program Project Grant. Date: August 15, 2006. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call). Contact Person: Holly Patton, Scientific Review Administrator, Review Branch/ Division of Extramural Affairs, Nation Heart, Lung, and Blood Institute, Two Rockledge Center, 6701 Rockledge Drive Room 7188, Bethesda, MD 20892. (301) 435–0280. pattonh@nhlbi.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: July 24, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–6544 Filed 7–27–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordancd with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant E:\FR\FM\28JYN1.SGM 28JYN1

Agencies

[Federal Register Volume 71, Number 145 (Friday, July 28, 2006)]
[Notices]
[Page 42860]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6548]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Alternative Medicine; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Advisory Council for Complementary and Alternative Medicine (NACCAM) 
meeting.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), 
Title 5 U.S.C., as amended. The grant applications and/or contract 
proposals and the discussions could disclose confidential trade secrets 
or commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Complementary 
and Alternative Medicine.
    Date: September 8, 2006.
    Closed: 9 am. to 2 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Open: 2 p.m. to 4 p.m.
    Agenda: Presentations of new research initiatives, and other 
council related business.
    Place: National Institutes of Health, Neuroscience Building, 
6001 Executive Boulevard, Rooms C & D, Rockville, MD 20852.
    Contact Person: Martin H. Goldrosen, PhD, Executive Secretary, 
National Center for Complementary and Alternative Medicine, National 
Institutes of Health, 6707 Democracy Blvd., Suite 401, Bethesda, MD 
20892, (301) 594-2014.
    The public comments session is scheduled from 3:30-4p.m. but 
could change depending on the actual time spent on each agenda item. 
Each speaker will be permitted 5 minutes for their presentation. 
Interested individuals and representatives of organizations are 
requested to notify Dr. Martin H. Goldrosen, National Center for 
Complementary and Alternative Medicine, NIH, 6707 Democracy 
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax: 
301-480-9970. Letters of intent to present comments, along with a 
brief description of the organization represented, should be 
received no later than 5 p.m. on August 29, 2006. Only one 
representative of an organization may present oral comments. Any 
person attending the meeting who does not request an opportunity to 
speak in advance of the meeting may be considered for oral 
presentation, if time permits, and at the discretion of the 
Chairperson. In addition, written comments may be submitted to Dr. 
Martin H. Goldrosen at the address listed above up to ten calendar 
days (September 18, 2006) following the meeting.
    Copies of the meeting agenda and the roster of members will be 
furnished upon request by contacting Dr. Martin H. Goldrosen, 
Executive Secretary, NACCAM, National Center for Complementary and 
Alternative Medicine, National Institutes of Health, 6707 Democracy 
Boulevard, Suite 401, Bethesda, Maryland 20892, 301-594-2014, Fax: 
301-480-9970, or via e-mail at naccames@mail.nih.gov. In the 
interest of security, NIH has instituted stringent procedures for 
entrance into the building by nongovernment employees. Persons 
without a government I.D. will need to show a photo I.D. and sign-in 
at the security desk upon entering the building.

    Dated: July 24, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-6548 Filed 7-26-06; 8:45 am]
BILLING CODE 4167-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.